| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/16/1999 | US5872226 Fibroblast growth factor homologous factor-1 (FHF-1) |
| 02/16/1999 | US5872222 Conjugate comprises nonimmunogenic polymer coupled with a plurality of binding molecules, each being specific for an antigen on a t cell, and binding molecule lacking an fc portion |
| 02/16/1999 | US5872114 Therapeutic methods and delivery systems utilizing sex steroid precursors |
| 02/16/1999 | US5872106 Antimessenger oligonucleotide against urokinase receptor |
| 02/16/1999 | US5871802 Animal feed pelleting process and animal feed pellets produced therefrom |
| 02/16/1999 | US5871798 Method of making water based beverages |
| 02/16/1999 | US5871781 Apparatus for making rapidly-dissolving dosage units |
| 02/16/1999 | US5871778 Sustained release microsphere preparation containing antipsychotic drug |
| 02/16/1999 | US5871777 Incorporation of biologically active molecules into bioactive glasses |
| 02/16/1999 | US5871776 Controlled-release nifedipine |
| 02/16/1999 | US5871775 Controlled release pharmaceutical compositions for the oral administration containing nifedipine as active substance |
| 02/16/1999 | US5871774 Drug units and methods for use |
| 02/16/1999 | US5871771 Micronized biodegradable particles, process for preparing them and use thereof |
| 02/16/1999 | US5871770 Delivering a fluid-sensitive beneficial agent such as a somatotropin, or an analogue or derivative thereof to an animal such as a bovine |
| 02/16/1999 | US5871769 Using magnesium gluconate alone or in combination with antioxidants selected from vitamin e, selenium, glutathione, isopropyl glutathionate and n-acetylcysteine; prevention of oxygen free radical and lipid peroxidation production |
| 02/16/1999 | US5871767 Implanting in patient immunoisolatory vehicle comprising core containing living cells which secrete biologically active material dispersed in biocompatible matrix, surrounded by biocompatible external jacket |
| 02/16/1999 | US5871765 Non-aqueous controlled release pest and air care gel composition |
| 02/16/1999 | US5871751 Oral vaccine for infection from renibacterium |
| 02/16/1999 | US5871747 Antigen-carrying microparticles and their use in the indication of humoral or cellular responses |
| 02/16/1999 | US5871736 Liquid immunoglobulin formulations |
| 02/16/1999 | US5871722 Ionic beads useful for controlled release and adsorption |
| 02/16/1999 | US5871607 Material having a substance protected by deformable standoffs and method of making |
| 02/16/1999 | US5871478 Implantable drug delivery means |
| 02/16/1999 | US5871472 To preselected brain areas |
| 02/16/1999 | CA2153234C Aqueous drug composition having property of reversible thermosetting gelation |
| 02/16/1999 | CA2152795C Readily available konjac glucomannan sustained release excipient |
| 02/16/1999 | CA2104733C Urea/lactate topical compositions for dry skin |
| 02/16/1999 | CA2084919C Sustained release tablets |
| 02/14/1999 | CA2211778A1 Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents |
| 02/11/1999 | WO1999006070A1 Switchable viscoelastic systems containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006065A1 Aqueous preparation of lactoferrin having improved stability |
| 02/11/1999 | WO1999006057A1 Soya extract, process for its preparation and pharmaceutical composition |
| 02/11/1999 | WO1999006055A1 Polynucleotide compositions |
| 02/11/1999 | WO1999006051A1 Pharmaceutical compositions containing vitamin d and calcium, their preparation and therapeutic use |
| 02/11/1999 | WO1999006046A1 Combinations of hmg-coa reductase inhibitors and nicotinic acid and methods for treating hyperlipidemia |
| 02/11/1999 | WO1999006045A1 Controlled release pharmaceutical compositions containing tiagabine |
| 02/11/1999 | WO1999006044A1 Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation |
| 02/11/1999 | WO1999006043A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | WO1999006038A1 Fast-acting analgesic |
| 02/11/1999 | WO1999006035A2 COMBINATIONS OF HMG-CoA REDUCTASE INHIBITORS AND NICOTINIC ACID COMPOUNDS AND METHODS FOR TREATING HYPERLIPIDEMIA ONCE A DAY AT NIGHT |
| 02/11/1999 | WO1999006032A2 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
| 02/11/1999 | WO1999006031A1 Pharmaceutical formulation for camptothecin analogues in gelatin capsule |
| 02/11/1999 | WO1999006030A1 Local oral herbal slow release tablets |
| 02/11/1999 | WO1999006029A1 Ascorbic acid-based formulation with improved colour stability |
| 02/11/1999 | WO1999006028A1 Method for preparing an extract of active principles in the form of microgranules based on dietary fibres |
| 02/11/1999 | WO1999006027A1 Pellet-type formulation intended for treating the intestinal tract |
| 02/11/1999 | WO1999006026A1 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 02/11/1999 | WO1999006025A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 02/11/1999 | WO1999006024A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | WO1999006023A1 Ophthalmic compositions containing galactomannan polymers and borate |
| 02/11/1999 | WO1999006022A1 Artificial tear formulation |
| 02/11/1999 | WO1999006011A2 Shellac-containing cosmetic product |
| 02/11/1999 | WO1999005989A2 Devices for providing therapeutic substances |
| 02/11/1999 | WO1998051290A3 Local anesthetic formulations comprising a site 1 sodium channel blocker combined with a second active agent |
| 02/11/1999 | WO1998046287A3 Drug delivery via therapeutic hydrogels |
| 02/11/1999 | WO1998033528A3 Induction of b cell tolerance |
| 02/11/1999 | DE19734011A1 Preparation of solid dosage forms with polymeric binder |
| 02/11/1999 | DE19733981A1 Transdermales Therapeutisches System (TTS) zur Abgabe von Wirkstoff durch die Haut an einen Organismus und Verfahren zur Applikation auf der Haut Transdermal therapeutic system (TTS) for delivering active ingredient through the skin to a body and method for application to the skin |
| 02/11/1999 | CA2298624A1 Ascorbic acid-based formulation having improved colour stability |
| 02/11/1999 | CA2297270A1 Method for preparing an extract of active principles in the form of microgranules based on dietary fibres |
| 02/11/1999 | CA2296394A1 Stable particulate complexes with neutral or negative global charge of lamellar structure |
| 02/11/1999 | CA2294032A1 Self-emulsifying formulation for lipophilic compounds |
| 02/11/1999 | CA2294024A1 Shellac-containing cosmetic product |
| 02/11/1999 | CA2244619A1 Crystalline progestagens |
| 02/10/1999 | EP0895783A2 Pharmaceutical composition comprising ifosfamide and carnitine |
| 02/10/1999 | EP0895782A2 Pharmaceutical compositions of Cilansetron stabilized against racemisation |
| 02/10/1999 | EP0895780A1 Extended release tablets particularly containing pseudoephedrine hydrochloride |
| 02/10/1999 | EP0895474A1 Liquid eye drop composition |
| 02/10/1999 | EP0895473A1 Polysaccharide microspheres for the pulmonary delivery of drugs |
| 02/10/1999 | EP0719138B1 Iontophoretic delivery of an antimigraine drug |
| 02/10/1999 | EP0659174B1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 02/10/1999 | CN1207810A Storage-stable particle, in particular carrier for carrier-bound reactions, and methods of producing said particle |
| 02/10/1999 | CN1207755A Compositions comprising hydroxy-functional polymers |
| 02/10/1999 | CN1207749A Process for preparation of porous polyolefin particles |
| 02/10/1999 | CN1207684A Enzymatic method and compositions for treating intravitreal hemorrhagic blood |
| 02/10/1999 | CN1207683A Cytokine and Hemopoietic factor endogenous production enhancer and method of use thereof |
| 02/10/1999 | CN1207681A Sustained-release microgranules contg. diltiazem as active principle |
| 02/10/1999 | CN1207680A Use of certain isoquinolinesulfonyl compounds for treatment of glaucoma and ocular ischemia |
| 02/10/1999 | CN1207677A Pharmaceutical compositions comprising flurbiprofen |
| 02/10/1999 | CN1207675A Sublingual and buccal administration of selegiline |
| 02/10/1999 | CN1207674A Granular preparation and process for producing same |
| 02/10/1999 | CN1207673A Endoparasiticidal agents |
| 02/10/1999 | CN1207672A Modified release oral pharmaceutical composition contg. 5-ASA and method for treatment of bowel diseases |
| 02/10/1999 | CN1207671A PGE-1 contg. lyophilized liposomes for use in treatment of erectile dysfunction |
| 02/10/1999 | CN1207318A Ointment for treating burn and scald |
| 02/10/1999 | CN1207317A Fat regulating tablet for treating hyperlipidemia and preparing method thereof |
| 02/10/1999 | CN1207312A Capsule for treating apoplexy sequela and its producing method |
| 02/10/1999 | CN1207299A Method for preparing suppository (or ointment) for treating pile |
| 02/10/1999 | CN1207298A Fistula recovery ointment and preparing process thereof |
| 02/10/1999 | CN1207297A Process for producing royal jelly freeze-dried powder |
| 02/10/1999 | CN1207296A Method for preparing pantocrine injection |
| 02/10/1999 | CN1207295A Medical preparation for feet |
| 02/10/1999 | CN1207294A Potassium and magnesium controlled-release tablet and producing method thereof |
| 02/10/1999 | CN1207292A Stable anti-racemic medicinal preparation of cilancetlone |
| 02/10/1999 | CN1207252A Ginseng Chewing-gum |
| 02/09/1999 | US5869715 Cationic monoamine compound (quaternary ammonium or tertiary amine salt with 2 halogenated aliphatic groups and 2 ethers or esters) for transporting biologically active species through membrane barriers; nonviral |
| 02/09/1999 | US5869711 Ceramide compounds, process for their preparation and use |
| 02/09/1999 | US5869703 Nonionic vitamin E derivatives and a method for the preparation thereof, and polymeric ampliphilic vesicles made therefrom |
| 02/09/1999 | US5869652 Process for producing active substances from unused or discarded devices for the transdermal administration |
| 02/09/1999 | US5869540 Herbal treatments for improving skin appearance |